Results 1 to 10 of about 25,780 (241)

Real-Time Positron Emission Tomography Evaluation of Topotecan Brain Kinetics after Ultrasound-Mediated Blood–Brain Barrier Permeability

open access: yesPharmaceutics, 2021
Glioblastoma (GBM) is the most common primary adult brain malignancy with an extremely poor prognosis and a median survival of fewer than two years.
Andrei Molotkov   +11 more
doaj   +3 more sources

Elucidation of Mechanisms of Topotecan-Induced Cell Death in Human Breast MCF-7 Cancer Cells by Gene Expression Analysis

open access: yesFrontiers in Genetics, 2020
Topotecan is a clinically active anticancer agent for the management of various human tumors. While the principal mechanism of tumor cell killing by topotecan is due to its interactions with topoisomerase I and formation of DNA double-strand breaks ...
Birandra K. Sinha   +2 more
doaj   +2 more sources

Loss of ELF2 drives topotecan resistance in retinoblastoma revealed by genome-wide CRISPR-Cas9 screening [PDF]

open access: yesCell Death and Disease
The topoisomerase I inhibitor topotecan is an effective chemotherapeutic agent for retinoblastoma; however, treatment resistance remains a major clinical challenge, and its mechanisms remain elusive.
Jingyi Jiang   +14 more
doaj   +2 more sources

HIF inhibitor topotecan has a neuroprotective effect in a murine retinal ischemia-reperfusion model [PDF]

open access: yesPeerJ, 2019
Purpose The therapeutic approach for retinal ganglion cell (RGC) degeneration has not been fully established. Recently, it has been reported that hypoxia-inducible factor (HIF) may be involved with retinal neurodegeneration.
Hiromitsu Kunimi   +4 more
doaj   +3 more sources

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells

open access: yesFrontiers in Oncology, 2019
The purpose of this study was to examine pazopanib/topotecan combination activity vs. pazopanib monotherapy on anaplastic thyroid cancer (ATC) cells.
Teresa Di Desidero   +3 more
doaj   +2 more sources

Establishment and Characterization of a Topotecan Resistant Non-small Cell Lung Cancer NCI-H460/TPT10 Cell Line

open access: yesFrontiers in Cell and Developmental Biology, 2020
While topotecan (TPT) is a first- and second-line chemotherapeutic drug in treating lung cancer, the development of drug resistance in tumors still reserves as a major obstacle to chemotherapeutic success.
Zi-Ning Lei   +12 more
doaj   +2 more sources

In Vitro Stability and Preclinical Safety Evaluation of High-Dose Intravitreal Topotecan in Rabbits: Impact of Dose and Concentration [PDF]

open access: yesOphthalmology Science
Purpose: To assess the stability of concentrated solutions of topotecan and the ocular and systemic safety of administering repeated very high doses of intravitreal (IVi) topotecan in rabbits. Design: Experimental study.
María J. Del Sole, PhD   +8 more
doaj   +2 more sources

Efficacy and Safety of Rovalpituzumab Tesirine Compared with Topotecan as Second-Line Therapy in DLL3-High Small Cell Lung Cancer: Results from the Phase 3 TAHOE Study.

open access: yesJournal of Thoracic Oncology, 2021
INTRODUCTION Delta-like protein 3 (DLL3), an atypical Notch ligand, is expressed in small cell lung cancer (SCLC) tumors but is not detectable in normal adult tissues.
F. Blackhall   +23 more
semanticscholar   +1 more source

Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial.

open access: yesJAMA Oncology, 2023
Importance Patients with relapsed small cell lung cancer (SCLC), a high replication stress tumor, have poor prognoses and few therapeutic options. A phase 2 study showed antitumor activity with the addition of the ataxia telangiectasia and Rad3-related ...
N. Takahashi   +37 more
semanticscholar   +1 more source

Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer

open access: yesCancers, 2023
Simple Summary In this retrospective analysis of 72 advanced ovarian cancer patients, we have evaluated the safety and activity of orally-administered metronomic chemotherapy (MC) based on single agent topotecan or a combination of topotecan and ...
P. Wysocki   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy